Heptanon 5 mg tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

heptanon 5 mg tablete

pliva ljubljana d.o.o., ljubljana - metadon - tableta - metadon 4,48 mg / 1 tableta - metadon

MANIT 100 mg/ml raztopina za infundiranje Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

manit 100 mg/ml raztopina za infundiranje

hrvatski zavod za transfuzijsku medicinu - manitol; natrijev acetat trihidrat; natrijev klorid - raztopina za infundiranje - manitol 100 mg / 1 ml  natrijev acetat trihidrat2,4 mg / 1 ml  natrijev klorid2,6 mg / 1 ml; natrijev acetat trihidrat 2,4 mg / 1 ml  natrijev klorid2,6 mg / 1 ml; natrijev klorid 2,6 mg / 1 ml - manitol

Heptanon 10 mg/ml peroralna raztopina Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

heptanon 10 mg/ml peroralna raztopina

pliva ljubljana d.o.o., ljubljana - metadon - peroralna raztopina - metadon 8,95 mg / 1 ml - metadon

Heptanon 10 mg/ml raztopina za injiciranje Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

heptanon 10 mg/ml raztopina za injiciranje

pliva ljubljana d.o.o., ljubljana - metadon - raztopina za injiciranje - metadon 8,95 mg / 1 ml - metadon

Heptanon 10 mg/ml peroralne kapljice, raztopina Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

heptanon 10 mg/ml peroralne kapljice, raztopina

pliva ljubljana d.o.o., ljubljana - metadon - peroralne kapljice, raztopina - metadon 8,95 mg / 1 ml - metadon

MANIT 200 mg/ml raztopina za infundiranje Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

manit 200 mg/ml raztopina za infundiranje

hrvatski zavod za transfuzijsku medicinu - manitol - raztopina za infundiranje - manitol 200 mg / 1 ml - manitol

Cardalis Evropska unija - slovenščina - EMA (European Medicines Agency)

cardalis

ceva santé animale - benazepril hydrochloride, spironolactone - srČno-Žilni sistem - psi - za zdravljenje kongestivnega srčnega popuščanja, ki ga povzroča kronična degenerativna bolezen valvularov pri psih (z ustrezno diuretično podporo).

ReFacto AF Evropska unija - slovenščina - EMA (European Medicines Agency)

refacto af

pfizer europe ma eeig - moroktokog alfa - hemofilija a - antihemoragije - zdravljenje in preventivo za krvavitev pri bolnikih s hemofilija a (prirojeno faktor viii pomanjkljivost). refacto af je primerno za uporabo pri odraslih in otrocih vseh starosti, vključno z dojenčki. refacto af ne vsebuje von-willebrand dejavnik, in zato ni prikazana v von-willebrand je bolezen.

Xeljanz Evropska unija - slovenščina - EMA (European Medicines Agency)

xeljanz

pfizer europe ma eeig - tofacitinib - artritis, revmatoidni - imunosupresivi - rheumatoid arthritistofacitinib in combination with methotrexate (mtx) is indicated for the treatment of moderate to severe active rheumatoid arthritis (ra) in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying antirheumatic drugs (dmards) (see section 5. tofacitinib can be given as monotherapy in case of intolerance to mtx or when treatment with mtx is inappropriate (see sections 4. 4 in 4. psoriatic arthritistofacitinib in combination with mtx is indicated for the treatment of active psoriatic arthritis (psa) in adult patients who have had an inadequate response or who have been intolerant to a prior disease modifying antirheumatic drug (dmard) therapy (see section 5. ulcerative colitistofacitinib is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent (see section 5. tofacitinib is indicated for the treatment of active polyarticular juvenile idiopathic arthritis (rheumatoid factor positive [rf+] or negative [rf-] polyarthritis and extended oligoarthritis), and juvenile psoriatic arthritis (psa) in patients 2 years of age and older, who have responded inadequately to previous therapy with disease modifying antirheumatic drugs (dmards). tofacitinib can be given in combination with methotrexate (mtx) or as monotherapy in case of intolerance to mtx or where continued treatment with mtx is inappropriate. ankylosing spondylitistofacitinib is indicated for the treatment of adult patients with active ankylosing spondylitis (as) who have responded inadequately to conventional therapy.

Ciprinol 250 mg filmsko obložene tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

ciprinol 250 mg filmsko obložene tablete

krka, d.d., novo mesto - ciprofloksacin - filmsko obložena tableta - ciprofloksacin 250 mg / 1 tableta - ciprofloksacin